These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32941462)

  • 1. Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids.
    Parikh TJ; Stryczek KC; Gillespie C; Sayre GG; Feemster L; Udris E; Majerczyk B; Rinne ST; Wiener RS; Au DH; Helfrich CD
    PLoS One; 2020; 15(9):e0238511. PubMed ID: 32941462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of COPD patients of the proposed withdrawal of inhaled corticosteroids prescribed outside guidelines: A qualitative study.
    Gilworth G; Harries T; Corrigan C; Thomas M; White P
    Chron Respir Dis; 2019; 16():1479973119855880. PubMed ID: 31195812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers' Perspectives.
    Stryczek K; Lea C; Gillespie C; Sayre G; Wanner S; Rinne ST; Wiener RS; Feemster L; Udris E; Au DH; Helfrich CD
    J Gen Intern Med; 2020 Jan; 35(1):51-56. PubMed ID: 31396814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Value Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease and the Association with Healthcare Utilization and Costs.
    Duan KI; Spece LJ; Wong ES; Feemster LC; Donovan LM; Griffith MF; Keller TL; Bryant AD; Au DH
    Ann Am Thorac Soc; 2021 Jun; 18(6):989-996. PubMed ID: 33290180
    [No Abstract]   [Full Text] [Related]  

  • 5. Initiating Low-Value Inhaled Corticosteroids in an Inception Cohort with Chronic Obstructive Pulmonary Disease.
    Spece LJ; Donovan LM; Griffith MF; Keller T; Feemster LC; Smith NL; Au DH
    Ann Am Thorac Soc; 2020 May; 17(5):589-595. PubMed ID: 31899652
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
    Román-Rodríguez M; van Boven JF; Vargas F; Contreras CC; Lamelas G; Gestoso S; Góngora M; Corredor M; Esteva M
    Eur J Gen Pract; 2016 Dec; 22(4):232-239. PubMed ID: 27597172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication Discontinuation in Adults With COPD Discharged From the Hospital: A Population-Based Cohort Study.
    Gershon AS; McGihon RE; Thiruchelvam D; To T; Wu R; Bell CM; Aaron SD;
    Chest; 2021 Mar; 159(3):975-984. PubMed ID: 33011204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids.
    Menckeberg TT; Bouvy ML; Bracke M; Hugtenburg JG; Lammers JW; Raaijmakers JA
    Br J Clin Pharmacol; 2008 Aug; 66(2):255-60. PubMed ID: 18717916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overuse and Misuse of Inhaled Corticosteroids Among Veterans with COPD: a Cross-sectional Study Evaluating Targets for De-implementation.
    Griffith MF; Feemster LC; Zeliadt SB; Donovan LM; Spece LJ; Udris EM; Au DH
    J Gen Intern Med; 2020 Mar; 35(3):679-686. PubMed ID: 31713043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
    Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.
    Sliwka A; Jankowski M; Gross-Sondej I; Storman M; Nowobilski R; Bala MM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012355. PubMed ID: 30141826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.
    Kaplan AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2535-48. PubMed ID: 26648711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
    Horita N; Goto A; Shibata Y; Ota E; Nakashima K; Nagai K; Kaneko T
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012066. PubMed ID: 28185242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study.
    Magnussen H; Lucas S; Lapperre T; Quint JK; Dandurand RJ; Roche N; Papi A; Price D; Miravitlles M;
    Respir Res; 2021 Jan; 22(1):25. PubMed ID: 33478491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.
    Miravitlles M; Cosío BG; Arnedillo A; Calle M; Alcázar-Navarrete B; González C; Esteban C; Trigueros JA; Rodríguez González-Moro JM; Quintano Jiménez JA; Baloira A
    Respir Res; 2017 Nov; 18(1):198. PubMed ID: 29183382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden.
    Sulku J; Janson C; Melhus H; Malinovschi A; Ställberg B; Bröms K; Högman M; Lisspers K; Hammarlund-Udenaes M; Nielsen EI
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2451-2460. PubMed ID: 31806954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.